Linaclotide clinical trials: 31 trials
Page 1 of 1
Read 31 Linaclotide clinical trials with posted results or linked papers with results in PepBank.
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
NCT00730171 · Phase 3 · Completed
Posted results
- A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
NCT01880424 · Phase 3 · Completed
Posted results
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation
NCT00765999 · Phase 3 · Completed
Posted results
- Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
NCT02291679 · Phase 3 · Completed
Posted results
- An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
NCT02590432 · Phase 4 · Completed
Posted results
- Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
NCT00938717 · Phase 3 · Completed
Posted results
- Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation
NCT00948818 · Phase 3 · Completed
Posted results
- Trial of Linaclotide in Patients With Chronic Constipation
NCT00730015 · Phase 3 · Completed
Posted results
- Phase III, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation
NCT00765882 · Phase 3 · Completed
Posted results
- A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
NCT03573908 · Phase 3 · Completed
Posted results
- Safety and Efficacy of Linaclotide in Patients With Chronic Constipation and Prominent Abdominal Bloating
NCT01642914 · Phase 3 · Completed
Posted results
- Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)
NCT04026113 · Phase 3 · Completed
Posted results
- Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-C
NCT04166058 · Phase 3 · Completed
Posted results
- A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional Constipation
NCT05652205 · Phase 3 · Completed
Posted results
- A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C)
NCT02837783 · Phase 4 · Terminated
Posted results
- Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome
NCT02316899 · Phase 3 · Completed
Linked paper with results
- Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders
NCT05134584 · Phase 4 · Status unknown
Linked paper with results
- Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
NCT02559206 · Phase 2 · Completed
Posted results
- Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
NCT00460811 · Phase 2 · Completed
Posted results
- Dose-range-finding, Phase 2 Trial of Oral Linaclotide Acetate Administered to Patients With Chronic Constipation
NCT00402337 · Phase 2 · Completed
Posted results
- Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
NCT02270983 · Phase 2 · Completed
Posted results
- A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
NCT02559570 · Phase 2 · Completed
Posted results
- A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
NCT02559817 · Phase 2 · Terminated
Posted results
- Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation
NCT04110145 · Phase 2 · Completed
Posted results
- A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With Linaclotide
NCT05760313 · Phase 2 · Completed
Posted results
- A Study to Evaluate Dose Responses of Efficacy and Safety of ASP0456 in Patient With Chronic Constipation
NCT02425722 · Phase 2 · Completed
Linked paper with results
- Proof of Principle Study for an Efficacy Trial of Linaclotide for Cystic Fibrosis
NCT07569419 · Early phase 1 · Recruiting
Linked paper with results
- Efficacy of Linaclotide to Senna for CIC
NCT02239510 · Not applicable · Terminated
Posted results
- Application of Linaclotide Capsule in Bowel Preparation for Colonoscopy
NCT05291325 · Not applicable · Completed
Linked paper with results
- Effect and Safety of Polyethylene Glycol Combined With Linaclotide on Colon Cleansing for Patients With Chronic Constipation
NCT05137145 · Not applicable · Status unknown
Linked paper with results
- Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients
NCT02078323 · Not applicable · Completed
Linked paper with results